小鼠单核巨噬细胞白血病细胞RAW264.7 (种属鉴定)
价格:¥电议
品牌名称:$brandModel.Title(进口品牌)型号:FH0328 原产地:中国大陆 发布时间:2024/6/4 15:36:17更新时间:
产品完善度: 访问次数:
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:1年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:3402
参观次数:111970
详细内容
产品详情 说明书 参考文献
1、Liu Z, Zhang N, Xin B, Shi Y, Liang Z, Wan Y, Hu X. Exosomes from LSD1 knockdown breast cancer cells activate osteoclastogenesis and inhibit osteoblastogenesis. Int J Biol Macromol. 2023 Feb 22;235:123792. doi: 10.1016/j.ijbiomac.2023.123792. Epub ahead of print. PMID: 36828097. 2、Wei M, Liu F, Raka RN, Xiang J, Xiao J, Han T, Guo F, Yang S, Wu H. In vitro and in silico analysis of 'Taikong blue' lavender essential oil in LPS-induced HaCaT cells and RAW264.7 murine macrophages. BMC Complement Med Ther. 2022 Dec 6;22(1):324. doi: 10.1186/s12906-022-03800-0. PMID: 36474235; PMCID: PMC9727978. 3、Li Y, Zhuang Q, Tao L, Zheng K, Chen S, Yang Y, Feng C, Wang Z, Shi H, Shi J, Fang Y, Xiao L, Geng D, Wang Z. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway. Cell Prolif. 2022 Oct;55(10):e13291. doi: 10.1111/cpr.13291. Epub 2022 Jun 16. PMID: 35708050; PMCID: PMC9528769. 4、He M, Hu C, Chen M, Gao Q, Li L, Tian W. Effects of Gentiopicroside on activation of NLRP3 inflammasome in acute gouty arthritis mice induced by MSU. J Nat Med. 2022 Jan;76(1):178-187. doi: 10.1007/s11418-021-01571-5. Epub 2021 Sep 29. PMID: 34586567; PMCID: PMC8732881. 5、Huang J, Zhang S, Zhang S, Zhao Z, Cao Y, Chen M, Li B. A Comparative Study of Fluoroquinolone-Resistant Escherichia coli Lineages Portrays Indistinguishable Pathogenicity- and Survivability-Associated Phenotypic Characteristics Between ST1193 and ST131. Infect Drug Resist. 2020 Nov 20;13:4167-4175. doi: 10.2147/IDR.S277681. PMID: 33244246; PMCID: PMC7685377. 6、Wu X, Liu K, Wang R, Yang G, Lin J, Liu X. Multifunctional CuBiS2 Nanoparticles for Computed Tomography Guided Photothermal Therapy in Preventing Arterial Restenosis After Endovascular Treatment. Front Bioeng Biotechnol. 2020 Oct 21;8:585631. doi: 10.3389/fbioe.2020.585631. PMID: 33195149; PMCID: PMC7609917. |